Abstract: The invention relates to an assay for discriminating between amyotrophic lateral sclerosis (ALS) patients and patients with ALS-like disorders that express symptoms like ALS. The method is based on the use of 2-dimensional (2D) gel electrophoresis to separate the complex mixture of proteins found in blood serum, the quantitation of a group of identified biomarkers, and the biostatistical analysis of the concentration of the identified biomarkers to differentiate patients having ALS from patients having other ALS-like disorders.

Abstract: A method and an apparatus for separating a water/organic/solid emulsion, wherein the solid comprises particles having a length of about 50 .mu.m or less, are disclosed. The method comprises the steps of (1) directing the water/organic/solid emulsion from an emulsion source through a first hydrocyclone; (2) inverting the phase of the overflow emulsion from the first hydrocyclone; (3) directing the overflow emulsion through one or more subsequent hydrocyclones arranged in series; and (4) collecting the aqueous phase and the organic phase. The solid can be a biocatalyst, such as an intact bacterial, fungal or yeast cell. The organic phase is a liquid material substantially comprising carbon, which is substantially immiscible with water, such as petroleum.

Abstract: A bioreactor for separating contaminants from fluid and degrading the separated contaminants is disclosed.